Procter & Gamble (NYSE:PG) Stock Unloaded Rep. Julie Johnson

Representative Julie Johnson (D-Texas) recently sold shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on September 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on August 14th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 8/14/2025.
• Sold $1,001 – $15,000 in shares of Eli Lilly and Company (NYSE:LLY) on 8/14/2025.
• Sold $1,001 – $15,000 in shares of Arthur J. Gallagher & Co. (NYSE:AJG) on 8/14/2025.
• Sold $1,001 – $15,000 in shares of Parker-Hannifin (NYSE:PH) on 8/14/2025.
• Sold $1,001 – $15,000 in shares of Charles Schwab (NYSE:SCHW) on 8/14/2025.
• Sold $1,001 – $15,000 in shares of Fidelity National Information Services (NYSE:FIS) on 8/14/2025.
• Sold $1,001 – $15,000 in shares of ConocoPhillips (NYSE:COP) on 8/14/2025.
• Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 8/14/2025.
• Sold $1,001 – $15,000 in shares of Dover (NYSE:DOV) on 8/14/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 8/14/2025.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $157.32 on Friday. The company’s 50 day simple moving average is $156.17 and its 200-day simple moving average is $161.49. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The company has a market capitalization of $368.21 billion, a price-to-earnings ratio of 24.17, a price-to-earnings-growth ratio of 4.23 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the company posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a dividend of $1.0568 per share. The ex-dividend date was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is currently 64.98%.

Insiders Place Their Bets

In other Procter & Gamble news, COO Shailesh Jejurikar sold 13,039 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the completion of the transaction, the chief operating officer directly owned 28,036 shares of the company’s stock, valued at $4,409,221.72. This represents a 31.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the sale, the chief financial officer directly owned 52,642 shares of the company’s stock, valued at $8,279,007.34. The trade was a 18.11% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 120,181 shares of company stock valued at $18,918,012. Corporate insiders own 0.20% of the company’s stock.

Analyst Ratings Changes

PG has been the subject of several research reports. BNP Paribas reaffirmed an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Berenberg Bank lifted their price target on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday. Evercore ISI reissued an “in-line” rating and set a $170.00 target price (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Barclays set a $164.00 target price on Procter & Gamble and gave the stock an “equal weight” rating in a research note on Thursday, July 31st. Finally, UBS Group set a $180.00 price target on shares of Procter & Gamble and gave the stock a “buy” rating in a research note on Wednesday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $173.94.

Hedge Funds Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently made changes to their positions in the business. Nova Wealth Management Inc. purchased a new stake in shares of Procter & Gamble in the first quarter worth about $26,000. Signature Resources Capital Management LLC lifted its position in Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares in the last quarter. Capital A Wealth Management LLC purchased a new position in Procter & Gamble in the 4th quarter worth approximately $31,000. Quarry LP acquired a new stake in Procter & Gamble in the first quarter valued at approximately $33,000. Finally, 10Elms LLP purchased a new stake in shares of Procter & Gamble during the fourth quarter valued at approximately $34,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.